Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Transgenic mice for screening compounds with therapeutic potential against pain, hyper-thyroidism or obesity. These transgenic mice over-express DREAM, a transcriptional repressor More
Novel glycated peptide and protein biomarkers for glycemic control, as well as a method to monitor glycemic control in diabetic patients More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
The use of this technology could lead to improved diagnosis of individuals with early stage liver disease. More
The most desirable feature of this new compound is its ability to specifically inhibit O-GlcNAcase without targeting the related hexosaminidase A (HEX A) and hexoaminidase B (HEX B) enzymes. More
The technology provides methods for diagnosis and treatment of conditions such as cancer, diabetes, or other conditions that are influenced by AM levels. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Aug 2007 - 87 pages - $1,999
Feb 2010 - 19 pages - $500
Aug 2008 - 117 pages - $2,350
Feb 2012 - 1350 pages - $2,695
May 2011 - 102 pages - $3,835
Mar 2011 - 23 pages - $750
May 2011 - 15 pages - $250
Oct 2009 - 30 pages - $995
May 2011 - 15 pages - $125
Jul 2010 - 6 pages - $500
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us